Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-3940

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-3940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Label for Oxcarbazepine 150 mg film-coated tablets, quantity 30 tablets, labeled by RemedyRepack Inc. The label includes an NDC number 70518-3940-00, barcode, QR code, manufacturer information (Camber Pharma, Inc.), storage instructions, and note to see package insert for directions.*

FDA Label Image

Oxcarbazepinetabfig1 (Oxcarbazepinetabfig1)

A Kaplan-Meier curve graph showing exit rates over time from day 2 to day 11 of a clinical trial. The graph compares two treatment groups for Oxcarbazepine 150 mg oral tablets by RemedyRepack Inc., with a solid line for Oxcarbazepine and a dotted line for placebo. A log-rank test p-value of 0.0001 is displayed.*

FDA Label Image

Oxcarbazepinetabfig2 (Oxcarbazepinetabfig2)

A survival curve chart illustrating seizure rate over time in days from first dose to first seizure for two treatment groups: Oxcarbazepine and placebo. The X-axis shows days from 0 to over 130, and the Y-axis shows seizure rate from 0 to 1. The graph includes a log-rank test p-value of 0.046 comparing the groups.*

FDA Label Image

Oxcarbazepinetabfig3 (Oxcarbazepinetabfig3)

A Kaplan-Meier survival curve chart depicting exit rate over time (days) for two treatment groups labeled High (solid line) and Low (dashed line). The vertical axis represents exit rate from 0 to 1, and the horizontal axis shows time to exit up to 130 days. A log-rank test p-value of 0.0001 is noted, indicating a significant difference between the groups.*

FDA Label Image

Oxcarbazepinetabfig4 (Oxcarbazepinetabfig4)

A Kaplan-Meier survival curve showing exit rates over time in days for two treatment groups labeled 'HIGH' (solid line) and 'LOW' (dashed line). The graph includes a p-value of 0.0001 from a log-rank test, indicating a statistically significant difference between the groups. The vertical axis represents the exit rate, and the horizontal axis represents time to exit in days, up to 130 days.*

FDA Label Image

Oxcarbazepinetabstruct (Oxcarbazepinetabstruct)

Chemical structure of Oxcarbazepine, depicting its molecular framework with fused rings and functional groups, consistent with the generic drug Oxcarbazepine used in oral tablet form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.